4.3 Letter

Patients hospitalized with COVID-19 have low levels of 25-hydroxyvitamin D

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Vitamin D Status in Hospitalized Patients with SARS-CoV-2 Infection

Jose L. Hernandez et al.

Summary: The study found that hospitalized COVID-19 patients have significantly lower serum 25OHD levels than population-based controls, and the prevalence of vitamin D deficiency is higher in COVID-19 patients. However, no relationship was found between vitamin D concentrations or deficiency and the severity of the disease at this time.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Review Infectious Diseases

Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis

Jing Yang et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Article Medicine, General & Internal

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

Safiya Richardson et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Review Endocrinology & Metabolism

Vitamin D and COVID-19

John P. Bilezikian et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2020)

Review Cell Biology

Vitamin D and the intracrinology of innate immunity

Martin Hewison

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)